Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.

Singular Genomics Systems Inc

OMIC
20,01
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 01:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
27/2/202519:42EDGAR2Form 8-K - Current report
26/2/202502:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202502:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202502:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202502:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202502:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202514:00GLOBESingular Highlights Key G4X™ Launch Milestones and Showcases..
24/2/202506:15EDGAR2Form EFFECT - Notice of Effectiveness
21/2/202515:56GLOBESingular Genomics Announces Closing of Acquisition by..
21/2/202513:59EDGAR2Form S-8 POS - Securities to be offered to employees in..
21/2/202513:45EDGAR2Form POS AM - Post-Effective amendments for registration..
19/2/202523:26EDGAR2Form 8-K - Current report
14/2/202523:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202523:10EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
13/2/202523:08EDGAR2Form 8-K - Current report
07/1/202500:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/12/202423:23EDGAR2Form PREM14A - Preliminary proxy statements relating to..
23/12/202422:58EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/12/202422:56EDGAR2Form 8-K - Current report
23/12/202414:30GLOBESingular Genomics Enters into Agreement to be Acquired by..
17/12/202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202423:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202422:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202422:08EDGAR2Form 8-K - Current report
12/11/202422:05GLOBESingular Genomics Reports Recent Updates and Third Quarter..
04/11/202413:30EDGAR2Form 8-K - Current report
04/10/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202423:27EDGAR2Form 8-K - Current report
19/9/202423:24GLOBESingular Genomics Receives Non-Binding Acquisition Proposal..
18/9/202401:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202401:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202401:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202422:35EDGAR2Form 8-K - Current report
12/9/202422:31GLOBESingular Genomics Receives Non-Binding Acquisition Proposal..
14/8/202423:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202422:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/8/202422:06EDGAR2Form 8-K - Current report
13/8/202422:05GLOBESingular Genomics Reports Recent Highlights and Second..
07/8/202422:03EDGAR2Form 8-K - Current report
30/7/202423:05GLOBESingular Genomics to Report Second Quarter 2024 Financial..
15/7/202422:08EDGAR2Form 8-K - Current report
15/7/202422:05GLOBESingular Genomics Regains Compliance with Nasdaq Minimum Bid..
Apertura: Min: Max:
Chiusura: 20,01

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network